End-Stage Renal Disease

This article applies to people whose kidneys do not function. This condition is called end stage renal disease (ESRD). Today ESRD has a new and better treatment that can replace healthy kidneys. By knowing your treatment options you can work with your doctor to choose the best treatment for you. Whatever treatment you choose, there are some changes in your life. But with the help of your medical team, family and friends, you can live a fulfilling and active life.

Morbidity and mortality of patients with end stage renal disease remain high and the medical, social and economic impact of this disease is widespread. Heart disease is the leading cause of death in patients with end stage renal disease (Macias, Steward, & Oreopoulos, 2008). Primary care physicians and kidney specialists are essential to comprehensive care from the initial stage. Disease management is a dynamic process and dialysis or kidney transplantation is the only cure for this condition, but there is a conservative cure. It refers to management without dialysis, including aggressive management of kidney disease to delay the deterioration of kidney function and minimize the complications of the disease. It also includes proactive management of symptoms, psychological care, social support, family support. This includes detailed communication with patients and families, and pre-care planning. (O'connor &, Corcoran, 2012)

African Americans have the highest incidence of end stage renal disease in the United States. Blacks with chronic kidney disease are at high risk of dying before end stage renal disease and end stage renal disease. In 2004, the adjustment of age and sex of end-of-black renal disease was 6 times higher than non-black age (Derose, Rutkowski, Levin, Liu, Shi, Jacobsen, and Crooks, 2009). The race differences in the incidence of terminal kidney disease seems to be due to several population differences, including complications that affect the risk of kidney disease, the type and severity of kidney disease, and the mortality rate of end stage renal disease I will. Differences in these populations may be due to more distant causes such as fluctuations in gene expression, exposure to the environment, health-related behaviors, access to and access to health care, response to treatment (Derose, Rutkowski, Levin, Liu, Shi, Jacobsen). , & Crooks, 2009)